HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MEDTIDE

23.340

-0.100-0.43%

Volume:101.60K

Turnover:2.33M

Market Cap:3.31B

PE:12.27

High:23.600

Open:23.480

Low:22.440

Close:23.440

52wk High:41.540

52wk Low:19.000

Shares:141.80M

HK Float Shares:141.80M

Volume Ratio:0.98

T/O Rate:0.07%

Dividend:- -

Dividend Rate:- -

EPS(LYR):1.902

ROE:22.84%

ROA:8.84%

PB:1.79

PE(LYR):12.27

PS:4.98

Loading ...

Overview Company News Filings

Precision Peptide Develops Needle-Free Tirzepatide Transdermal Patch in U.S

Medtide Schedules Board Meeting to Review Interim Results

Hong Kong Stock CXO Sector Rallies; Will MEDTIDE (03880) Defy the Trend or Bounce Back After Its Profit Warning?

Cpc Scientific Announces U.S. FDA Pre-License Inspection (Pli) Successfully Completed at Its Hangzhou Cgmp Manufacturing Facility for Hepcludex® API, Establishing a Proven Track Record Under the Stringent Bla Pathway

THOMSON REUTERS

Medtide Posts Steady July 2026 Share Capital; Public Float Remains Compliant

Bulletin Express

Medtide completes U.S. FDA Pre-License Inspection for Hepcludex API at Hangzhou facility

Bulletin Express

MEDTIDE (03880) Issues Profit Warning, Expects First-Half Profit to Drop Approximately 44% to 51.6% Year-on-Year

MEDTIDE's HEPCLUDEX® Active Ingredient Passes FDA Pre-License Inspection

MEDTIDE Appoints New CFO and Revamps Key Management Positions

Medtide Unit Chinese Peptide Completes US FDA Pre-license Inspection for Hepcludex API Facility

Medtide Names Ding Lijun as CFO

Medtide - Subsidiary Completes U.S. FDA Pre-License Inspection at Hangzhou Facility

THOMSON REUTERS

Medtide Expects H1 Profit to Fall 44%-52% to RMB 49.4 million-RMB 57.1 Million

Medtide - Appoints Ding Lijun as Chief Financial Officer Effective July 31, 2026

THOMSON REUTERS

Medtide - Sees H1 2026 Revenue at Rmb229.8 Mln–RMB239.2 Mln, Down 5.7%–9.4% Y/Y

THOMSON REUTERS

Precision Peptide Closes $2 Million Share Offering Under Canadian LIFE Exemption

Precision Peptide Receives 20,000-unit Production Run of Bpc-157 Transdermal Patches

Precision Peptide Signs Exclusive Strategic Marketing Partnership with Mma.inc

MEDTIDE Reports No Change in Share Capital for June 2026; Public Float Remains Compliant

Bulletin Express

Medtide Updates Articles of Association: Sets Governance, Share Capital at 141.80 Million H Shares

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/03880/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"03880","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","market":"HK","secType":"STK","nameCN":"MEDTIDE","latestPrice":23.34,"timestamp":1787299159814,"preClose":23.44,"halted":0,"volume":101600,"delay":0,"changeRate":-0.004266211604095623,"floatShares":141800000,"shares":141800000,"eps":1.9020266762853937,"marketStatus":"Market Closed","change":-0.1,"latestTime":"08-21 15:59:19","open":23.48,"high":23.6,"low":22.44,"amount":2332618,"amplitude":0.049488,"askPrice":23.34,"askSize":800,"bidPrice":22.7,"bidSize":300,"shortable":0,"etf":0,"ttmEps":1.9802081408934438,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1751212800000,"exchange":"SEHK","adjPreClose":23.44,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.9801273397569467,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","floatShares":141800000,"roa":"8.84%","roe":"22.84%","lyrEps":1.902027,"volumeRatio":0.9801273397569467,"shares":141800000,"dividePrice":0,"high":23.6,"amplitude":0.049488,"preClose":23.44,"low":22.44,"week52Low":19,"pbRate":"1.79","psRate":"4.98","week52High":41.54,"institutionHeld":0,"latestPrice":23.34,"committee":-0.454545,"eps":1.9020266762853937,"divideRate":0,"volume":101600,"delay":0,"ttmEps":1.9802081408934438,"open":23.48,"prevYearClose":30.48,"prevWeekClose":21.64,"prevMonthClose":22.52,"prevQuarterClose":22.08,"fiveDayClose":21.64,"twentyDayClose":22.98,"sixtyDayClose":22.2,"earningDate":1787760000000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03880\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787794200000,"name":null,"time":"","dateTimestamp":1787760000000,"actualEps":null},{"date":"2026-03-30","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-29","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03880\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03880\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1754409600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03880\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03880","date":"2026-08-21","current":11.78664,"percent":0.283688,"low":11.049775,"twenty":12.633554,"median":31.917498,"eighty":38.145216,"high":89.502411,"avg":33.097075,"sd":21.500156,"marketCap":3309612000},"quantilePoints":[{"date":"2025-06-27","current":64.550519,"twenty":64.550519,"median":64.550519,"eighty":64.550519,"marketCap":4183100000},{"date":"2025-07-04","current":69.032987,"twenty":66.795355,"median":68.595377,"eighty":69.313609,"marketCap":4473790000},{"date":"2025-07-11","current":68.445519,"twenty":67.311524,"median":68.276633,"eighty":68.994281,"marketCap":4431250000},{"date":"2025-07-18","current":76.171108,"twenty":67.389311,"median":68.984604,"eighty":75.214843,"marketCap":4927550000},{"date":"2025-07-25","current":74.03868,"twenty":67.965697,"median":71.906475,"eighty":74.616858,"marketCap":4807020000},{"date":"2025-08-01","current":77.026259,"twenty":68.377965,"median":73.828208,"eighty":76.342138,"marketCap":4970090000},{"date":"2025-08-08","current":73.611635,"twenty":68.565405,"median":73.719922,"eighty":75.214843,"marketCap":4761644000},{"date":"2025-08-15","current":78.991101,"twenty":68.906759,"median":73.83709,"eighty":76.342138,"marketCap":5101964000},{"date":"2025-08-22","current":89.502411,"twenty":69.02331,"median":74.090002,"eighty":78.320217,"marketCap":5762752000},{"date":"2025-08-29","current":78.512395,"twenty":70.155476,"median":74.257083,"eighty":79.74991,"marketCap":5079276000},{"date":"2025-09-05","current":41.646228,"twenty":68.906759,"median":74.188856,"eighty":79.74991,"marketCap":5031064000},{"date":"2025-09-12","current":37.986037,"twenty":67.389311,"median":74.066692,"eighty":79.087699,"marketCap":4597156000},{"date":"2025-09-19","current":35.879032,"twenty":42.439428,"median":73.832649,"eighty":78.741923,"marketCap":4339080000},{"date":"2025-09-26","current":35.972365,"twenty":39.207677,"median":73.603619,"eighty":78.545842,"marketCap":4339080000},{"date":"2025-10-03","current":36.895298,"twenty":38.254613,"median":73.439791,"eighty":78.477782,"marketCap":4461028000},{"date":"2025-10-10","current":35.939087,"twenty":37.926552,"median":73.260895,"eighty":78.387462,"marketCap":4339080000},{"date":"2025-10-17","current":35.261849,"twenty":36.980504,"median":69.008796,"eighty":78.069934,"marketCap":4254000000},{"date":"2025-10-24","current":35.954012,"twenty":36.188249,"median":68.445519,"eighty":77.701013,"marketCap":4339080000},{"date":"2025-10-31","current":35.900465,"twenty":36.021695,"median":67.397498,"eighty":77.513348,"marketCap":4339080000},{"date":"2025-11-07","current":35.922904,"twenty":35.979492,"median":65.840942,"eighty":76.855229,"marketCap":4339080000},{"date":"2025-11-14","current":36.196001,"twenty":35.973277,"median":41.646228,"eighty":76.009632,"marketCap":4384456000},{"date":"2025-11-21","current":32.839875,"twenty":35.967307,"median":40.069862,"eighty":75.286139,"marketCap":3976072000},{"date":"2025-11-28","current":33.374508,"twenty":35.955467,"median":38.580928,"eighty":74.943808,"marketCap":4055480000},{"date":"2025-12-05","current":32.851251,"twenty":35.944759,"median":38.254067,"eighty":74.758171,"marketCap":3998760000},{"date":"2025-12-12","current":33.023157,"twenty":35.900465,"median":37.886895,"eighty":74.473119,"marketCap":4027120000},{"date":"2025-12-19","current":34.430381,"twenty":35.39442,"median":37.394857,"eighty":74.229792,"marketCap":4208624000},{"date":"2025-12-24","current":34.99421,"twenty":35.141853,"median":37.085683,"eighty":74.147921,"marketCap":4290868000},{"date":"2026-01-02","current":33.635992,"twenty":35.029056,"median":36.743987,"eighty":74.11624,"marketCap":4140560000},{"date":"2026-01-09","current":32.725127,"twenty":34.456149,"median":36.454304,"eighty":74.08534,"marketCap":4038464000},{"date":"2026-01-16","current":32.687847,"twenty":33.647972,"median":36.236629,"eighty":74.049885,"marketCap":4046972000},{"date":"2026-01-23","current":31.091299,"twenty":33.318703,"median":36.073206,"eighty":73.917726,"marketCap":3845616000},{"date":"2026-01-30","current":31.269354,"twenty":33.177249,"median":36.016394,"eighty":73.831761,"marketCap":3885320000},{"date":"2026-02-06","current":27.433753,"twenty":32.966335,"median":35.983345,"eighty":73.698264,"marketCap":3417380000},{"date":"2026-02-13","current":29.767101,"twenty":32.846701,"median":35.969241,"eighty":73.606825,"marketCap":3729340000},{"date":"2026-02-20","current":29.696692,"twenty":32.725127,"median":35.967659,"eighty":73.603619,"marketCap":3715160000},{"date":"2026-02-27","current":28.724265,"twenty":32.439619,"median":35.961022,"eighty":73.603001,"marketCap":3632916000},{"date":"2026-03-06","current":25.544273,"twenty":32.105235,"median":35.955322,"eighty":73.439791,"marketCap":3204680000},{"date":"2026-03-13","current":25.719686,"twenty":31.941403,"median":35.950844,"eighty":73.376851,"marketCap":3241548000},{"date":"2026-03-20","current":24.620311,"twenty":31.419436,"median":35.939087,"eighty":73.260895,"marketCap":3091240000},{"date":"2026-03-27","current":25.407751,"twenty":30.961293,"median":35.900465,"eighty":70.436098,"marketCap":3181992000},{"date":"2026-04-02","current":12.694395,"twenty":30.374151,"median":35.877946,"eighty":69.313609,"marketCap":3139452000},{"date":"2026-04-10","current":12.836208,"twenty":29.799581,"median":35.844414,"eighty":69.013634,"marketCap":3199008000},{"date":"2026-04-17","current":12.660198,"twenty":28.991894,"median":35.202659,"eighty":68.828913,"marketCap":3156468000},{"date":"2026-04-24","current":12.397874,"twenty":27.75939,"median":35.115214,"eighty":68.535434,"marketCap":3091240000},{"date":"2026-04-30","current":12.269611,"twenty":26.785787,"median":34.99421,"eighty":68.377965,"marketCap":3060044000},{"date":"2026-05-08","current":12.363155,"twenty":25.983648,"median":34.594549,"eighty":67.965697,"marketCap":3094076000},{"date":"2026-05-15","current":12.534163,"twenty":25.665008,"median":34.175169,"eighty":67.389311,"marketCap":3145124000},{"date":"2026-05-22","current":12.642172,"twenty":25.399381,"median":33.645975,"eighty":67.311524,"marketCap":3164976000},{"date":"2026-05-29","current":12.270986,"twenty":25.218458,"median":33.406025,"eighty":67.131365,"marketCap":3082732000},{"date":"2026-06-05","current":11.125953,"twenty":24.642571,"median":33.30501,"eighty":64.550519,"marketCap":2799132000},{"date":"2026-06-12","current":13.017265,"twenty":13.007169,"median":33.187074,"eighty":42.637728,"marketCap":3272744000},{"date":"2026-06-18","current":12.671021,"twenty":12.943368,"median":33.126975,"eighty":41.844528,"marketCap":3193336000},{"date":"2026-06-26","current":12.518344,"twenty":12.901138,"median":33.023157,"eighty":41.133711,"marketCap":3139452000},{"date":"2026-07-03","current":12.429887,"twenty":12.724861,"median":32.858736,"eighty":40.911062,"marketCap":3119600000},{"date":"2026-07-10","current":13.463401,"twenty":12.685266,"median":32.845563,"eighty":39.914225,"marketCap":3374840000},{"date":"2026-07-17","current":13.021079,"twenty":12.724861,"median":32.687847,"eighty":39.039678,"marketCap":3275580000},{"date":"2026-07-24","current":12.950528,"twenty":12.774507,"median":32.49883,"eighty":38.697228,"marketCap":3258564000},{"date":"2026-07-31","current":12.667228,"twenty":12.718655,"median":32.350921,"eighty":38.507791,"marketCap":3193336000},{"date":"2026-08-07","current":11.576024,"twenty":12.668745,"median":32.105235,"eighty":38.341571,"marketCap":2923916000},{"date":"2026-08-14","current":12.133289,"twenty":12.639428,"median":31.958711,"eighty":38.254613,"marketCap":3068552000},{"date":"2026-08-21","current":13.057601,"twenty":12.633554,"median":31.917498,"eighty":38.145216,"marketCap":3309612000}],"updateTime":1787473740350},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03880\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660473224","title":"Precision Peptide Develops Needle-Free Tirzepatide Transdermal Patch in U.S","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473224","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473224?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:04","pubTimestamp":1787137449,"startTime":"0","endTime":"0","summary":"Precision Peptide develops needle-free tirzepatide transdermal patch in U.SThe Precision Peptide Company is developing a needle-free tirzepatide transdermal patch in the U.S. as an expansion of its de","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL4zwmm5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660124483","title":"Medtide Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660124483","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660124483?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:34","pubTimestamp":1786955640,"startTime":"0","endTime":"0","summary":"Medtide schedules board meeting to review interim resultsMedtide will hold a board meeting on Aug. 27, 2026 to consider interim results for the six months ended June 30, 2026.Disclaimer:This news brie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL6Gc7j2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119829447","title":"Hong Kong Stock CXO Sector Rallies; Will MEDTIDE (03880) Defy the Trend or Bounce Back After Its Profit Warning?","url":"https://stock-news.laohu8.com/highlight/detail?id=1119829447","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119829447?lang=en_us&edition=fundamental","pubTime":"2026-08-07 10:26","pubTimestamp":1786069600,"startTime":"0","endTime":"0","summary":" On July 31, after the market close, MEDTIDE (03880) issued a profit warning for its 26H1 fiscal year. The company expects period revenue of approximately RMB 229.8-239.2 million, a year-over-year...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","VXUS","NIFE","03880","WX","BK1141","KCAI","CXO","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657544565","title":"Cpc Scientific Announces U.S. FDA Pre-License Inspection (Pli) Successfully Completed at Its Hangzhou Cgmp Manufacturing Facility for Hepcludex® API, Establishing a Proven Track Record Under the Stringent Bla Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2657544565","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657544565?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:11","pubTimestamp":1785931860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUA7VZCWP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150516282","title":"Medtide Posts Steady July 2026 Share Capital; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1150516282","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150516282?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:29","pubTimestamp":1785922152,"startTime":"0","endTime":"0","summary":"Medtide Inc. filed its Monthly Return for Equity Issuer for the period ended 31 July 2026, confirming that the company’s share structure remained unchanged throughout the month. • Authorised/Issued...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148679402","title":"Medtide completes U.S. FDA Pre-License Inspection for Hepcludex API at Hangzhou facility","url":"https://stock-news.laohu8.com/highlight/detail?id=1148679402","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148679402?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:47","pubTimestamp":1785487636,"startTime":"0","endTime":"0","summary":"Medtide Inc. (MEDTIDE) announced that its wholly owned subsidiary Chinese Peptide Company has passed a U.S. Food and Drug Administration Pre-License Inspection (PLI) for the commercial production of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120383613","title":"MEDTIDE (03880) Issues Profit Warning, Expects First-Half Profit to Drop Approximately 44% to 51.6% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1120383613","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120383613?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:44","pubTimestamp":1785487468,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has issued an announcement regarding its financial performance for the six months ending June 30, 2026, compared to the same period in 2025. The board anticipates that revenue will...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107085569","title":"MEDTIDE's HEPCLUDEX® Active Ingredient Passes FDA Pre-License Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=1107085569","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107085569?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:44","pubTimestamp":1785487449,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has announced that its wholly-owned subsidiary, Zhongtai Shenghua Co., Ltd. (\"Zhongtai Shenghua\"), has successfully completed a Pre-License Inspection (PLI) by the U.S. Food and Drug...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IPOS","BK1141","03880","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112713365","title":"MEDTIDE Appoints New CFO and Revamps Key Management Positions","url":"https://stock-news.laohu8.com/highlight/detail?id=1112713365","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112713365?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:38","pubTimestamp":1785487097,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has announced a series of key management changes, effective from July 31, 2026. Ms. Ding Lijun has been appointed as the Chief Financial Officer, where she will oversee the group's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655356459","title":"Medtide Unit Chinese Peptide Completes US FDA Pre-license Inspection for Hepcludex API Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2655356459","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655356459?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:35","pubTimestamp":1785486919,"startTime":"0","endTime":"0","summary":"Medtide unit Chinese Peptide completes US FDA pre-license inspection for Hepcludex API facilityChinese Peptide, a wholly owned Medtide subsidiary, cleared a US FDA pre-license inspection for Hepcludex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL8fHx2L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655356455","title":"Medtide Names Ding Lijun as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2655356455","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655356455?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:35","pubTimestamp":1785486901,"startTime":"0","endTime":"0","summary":"Medtide names Ding Lijun as CFONamed Ding Lijun as chief financial officer effective July 31, 2026; she was CFO of Inventronics (Hangzhou) from Feb 2025 to Jul 2026.Ding previously served as finance v","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL6fMHMp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300582","300577","BK1583","BK1161","BK1589","KURE","LU1969619763.USD","LU2097828714.EUR","LU0455707207.USD","BK0247","01801","03880","HK0000165453.HKD","LU2097828631.EUR","LU0502904849.HKD","LU2328871848.SGD","LU2488822045.USD","LU2097828474.EUR","LU2097828557.USD","LU2242644610.SGD","BK0214","LU2097828805.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655356956","title":"Medtide - Subsidiary Completes U.S. FDA Pre-License Inspection at Hangzhou Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2655356956","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655356956?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:33","pubTimestamp":1785486838,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X0T9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655919356","title":"Medtide Expects H1 Profit to Fall 44%-52% to RMB 49.4 million-RMB 57.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655919356","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655919356?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:33","pubTimestamp":1785486803,"startTime":"0","endTime":"0","summary":"Medtide expects H1 profit to fall 44%-52% to RMB 49.4 million-RMB 57.1 millionFlagged weaker 1H 2026 results: revenue RMB 229.8 million–RMB 239.2 million, down 5.7%–9.4% from RMB 253.8 million.Profit ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL67GtmB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655635667","title":"Medtide - Appoints Ding Lijun as Chief Financial Officer Effective July 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655635667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655635667?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:32","pubTimestamp":1785486768,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X0NK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655735695","title":"Medtide - Sees H1 2026 Revenue at Rmb229.8 Mln–RMB239.2 Mln, Down 5.7%–9.4% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2655735695","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655735695?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:32","pubTimestamp":1785486737,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X0KZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651145200","title":"Precision Peptide Closes $2 Million Share Offering Under Canadian LIFE Exemption","url":"https://stock-news.laohu8.com/highlight/detail?id=2651145200","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651145200?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:03","pubTimestamp":1784113410,"startTime":"0","endTime":"0","summary":"Precision Peptide closes $2 million share offering under Canadian LIFE exemptionThe Precision Peptide Company closed a non-brokered LIFE private placement, raising $2 million through 4,000,000 common ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL1jpgD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651774741","title":"Precision Peptide Receives 20,000-unit Production Run of Bpc-157 Transdermal Patches","url":"https://stock-news.laohu8.com/highlight/detail?id=2651774741","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651774741?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:02","pubTimestamp":1784026973,"startTime":"0","endTime":"0","summary":"Precision Peptide receives 20,000-unit production run of BPC-157 transdermal patchesThe Precision Peptide Company received about 20,000 BPC-157 transdermal patches, marking its shift from testing to c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDLkr8b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649986599","title":"Precision Peptide Signs Exclusive Strategic Marketing Partnership with Mma.inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2649986599","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649986599?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:05","pubTimestamp":1783508707,"startTime":"0","endTime":"0","summary":"Precision Peptide signs exclusive strategic marketing partnership with MMA.INCThe Precision Peptide Company signed an exclusive strategic marketing agreement with Mixed Martial Arts Group (MMA.INC) in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDLGHNRM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880","BK4192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108336724","title":"MEDTIDE Reports No Change in Share Capital for June 2026; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1108336724","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108336724?lang=en_us&edition=fundamental","pubTime":"2026-07-06 17:23","pubTimestamp":1783329818,"startTime":"0","endTime":"0","summary":"MEDTIDE (HKEX: 03880) has released its Monthly Return for Equity Issuer for the period ended 30 June 2026, confirming stability in its share structure and continued adherence to Hong Kong’s...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138756410","title":"Medtide Updates Articles of Association: Sets Governance, Share Capital at 141.80 Million H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1138756410","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138756410?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:43","pubTimestamp":1781783039,"startTime":"0","endTime":"0","summary":"Medtide Inc. (stock code: 03880, “Medtide”) has released a comprehensive revision of its Articles of Association, approved at the 18 June 2026 annual general meeting. The document reshapes the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}]}}